Icon

TARGRETIN (nda021055)- (75MG)

BEXAROTENE VALEANT LUXEMBOURG
75MG
Yes No
2016-Oct-05 Expired
None None
None No
TARGRETIN (bexarotene) is a retinoid indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
7 0 7
Total Other Developers None
Drugs with Suitability No
75MG ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********** ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ******** ******* ******* *********** **** ********** *****, *******, ******* *** ***, ****** (***) ***
****** ****** ****** ** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.